Earnings History Data for Milestone Pharmaceuticals Inc. (MIST) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals Inc. is based in Montr?al, Canada.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-08-2024 | PM | MIST | Milestone Pharmaceuticals Inc. | 71.37 | -0.14 | -0.19 | -0.37 | Milestone Pharmaceuticals GAAP EPS of -$0.14 [8/9/2024 6:17 AM] |
1.40 | -0.01 (-0.71%) |
1.31 | -0.10 (-6.93%) |
1.12 - 3.62 | 29,273 | 90,000 | 2,411 | ||
| 13-05-2024 | PM | MIST | Milestone Pharmaceuticals | 90.00 | -0.21 | -0.26 | 0.00 | Milestone Pharmaceuticals GAAP EPS of -$0.21 beats by $0.05 [5/13/2024 8:42 AM] |
1.70 | 0.0 (0.00%) |
1.68 | -0.02 (-1.18%) |
1.33 - 4.44 | 36,405 | 150,000 | 576 | ||
| 21-03-2024 | PM | MIST | Milestone Pharmaceuticals | 49.00 | -0.32 | -0.30 | 0.00 | Milestone Pharmaceuticals reports Q4 results [3/21/2024 12:32 PM] |
1.55 | 0.05 (3.64%) |
1.53 | 0.03 (2.00%) |
1.33 - 4.49 | 298,502 | 270,000 | 301 | ||
| 13-11-2023 | PM | MIST | Milestone Pharmaceuticals | 98.00 | -0.35 | -0.38 | 0.00 | Milestone Pharmaceuticals GAAP EPS of -$0.35 beats by $0.03 [11/13/2023 6:58 AM] |
2.35 | -0.56 (-19.24%) |
2.96 | 0.05 (1.72%) |
2.19 - 5.20 | 424,611 | 100,000 | 39,700 | ||
| 10-08-2023 | PM | MIST | Milestone Pharmaceuticals Inc. | 98.41 | -0.37 | -0.39 | -0.39 | Milestone Pharmaceuticals GAAP EPS of -$0.37 beats by $0.02 [8/10/2023 12:24 PM] |
3.13 | -0.17 (-5.15%) |
3.26 | -0.04 (-1.21%) |
2.73 - 9.85 | 75,292 | 220,000 | 2,452 | ||
| 29-03-2023 | AH | MIST | Milestone Pharmaceuticals Inc. | 116.23 | -0.31 | -0.35 | -0.40 | Milestone Pharmaceuticals GAAP EPS of -$0.31, revenue of $3.5M [3/29/2023 4:59 PM] |
3.89 | -0.01 (-0.26%) |
0.0 | 0.0 (0.00%) |
3.10 - 9.85 | 120,809 | 200,000 | 0 | ||
| 10-11-2022 | PM | Before the open (Nov 10) |
MIST | Milestone Pharmaceuticals | 127.00 | -0.34 | -0.41 | 0.00 | Milestone Pharmaceuticals GAAP EPS of -$0.34 beats by $0.07, revenue of $1.5M [11/10/2022 9:10 AM] |
4.49 | 0.40 (9.66%) |
0.0 | 0.0 (0.00%) |
3.98 - 9.85 | 697,239 | 870,000 | 0 | |
| 12-05-2022 | PM | 7:20 AM ET (May 12) |
MIST | Milestone Pharmaceuticals | 166.00 | -0.33 | -0.39 | 0.00 | Milestone Pharmaceuticals GAAP EPS of -$0.33 [5/12/2022 8:18 AM] |
5.13 | -0.41 (-7.40%) |
0.0 | 0.0 (0.00%) |
3.98 - 8.24 | 68,528 | 50,000 | 0 | |
| 17-05-2021 | PM | MIST | Milestone Pharmaceuticals Inc. | 157.00 | -0.30 | -0.33 | 0.00 | Milestone Pharmaceuticals EPS beats by $0.03 [5/17/2021 7:37 AM] |
5.64 | 0.09 (1.62%) |
5.56 | 0.01 (0.18%) |
3.08 - 11.40 | 85,016 | 50,000 | 3,454 | ||
|
||||||||||||||||||
| 13-11-2020 | PM | MIST | Milestone Pharmaceuticals Inc. | 159.00 | -0.40 | -0.49 | 0.00 | Milestone Pharmaceuticals EPS beats by $0.09 [11/13/2020 7:23 AM] |
6.31 | 0.11 (1.77%) |
6.11 | -0.09 (-1.45%) |
1.69 - 23.24 | 143,065 | 107,851 | 571 | ||
|
|
||||||||||||||||||
| 12-08-2020 | PM | MIST | Milestone Pharmaceuticals Inc. | 241.33 | -0.53 | -0.47 | -1.04 | Milestone Pharmaceuticals EPS misses by $0.06 [8/12/2020 7:06 AM] |
8.39 | -0.51 (-5.73%) |
9.34 | 0.44 (4.94%) |
1.69 - 24.01 | 282,765 | 1,453,880 | 3,550 | ||
|
|
||||||||||||||||||